What do Cochrane systematic reviews say about the use of cannabinoids in clinical practice?

What do Cochrane systematic reviews say about the use of cannabinoids in clinical practice?

ABSTRACT BACKGROUND: The therapeutic effects of cannabinoid compounds have been the center of many investigations. This study provides a synthesis on all Cochrane systematic reviews (SRs) that assessed the use of cannabinoids as a therapeutic approach. DESIGN AND SETTING: Review of SRs, conducte...

Full description

Bibliographic Details
Main Authors:	Carolina de Oliveira Cruz Latorraca, Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Daniela Vianna Pachito, Rachel Riera
Format:	Article
Language:	English
Published:	Associação Paulista de Medicina 2018-10-01
Series:	São Paulo Medical Journal
Subjects:	Review [publication type] Evidence-based medicine Evidence-based practice Cannabis Cannabinoids
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802018000500472&lng=en&tlng=en

Similar Items

What do Cochrane systematic reviews say about interventions for treating psoriasis?
by: Rafael Leite Pacheco, et al.
Published: (2018-08-01)

What do Cochrane systematic reviews say about interventions for vitamin D supplementation?
by: Mariana Vendramin Mateussi, et al.
Published: (2017-11-01)

What do Cochrane systematic reviews say about interventions for insomnia?
by: Florence de Lucca Melo, et al.

What do Cochrane systematic reviews say about the management of irritable bowel syndrome?
by: Rafael Leite Pacheco, et al.
Published: (2019-05-01)

What do Cochrane systematic reviews say about cardiac arrest management?
by: Rafael Leite Pacheco, et al.

What do Cochrane systematic reviews say about the clinical effectiveness of screening and diagnostic tests for cancer?
by: André Tito Pereira Bueno, et al.

What do Cochrane systematic reviews say about non-surgical interventions for urinary incontinence in women?
by: Anderson Adriano Leal Freitas da Costa, et al.

What do Cochrane systematic reviews say about probiotics as preventive interventions?
by: Vinícius Lopes Braga, et al.

What do Cochrane systematic reviews say about interventions for age-related macular degeneration?
by: Vania Mozetic, et al.
Published: (2020-03-01)

Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
by: Nadia Montero-Oleas, et al.
Published: (2020-01-01)

What do Cochrane systematic reviews say about interventions for retinal vein occlusion
by: Vânia Mozetic, et al.
Published: (2020-09-01)

Overview of Cochrane systematic review about retinal detachment
by: Vânia Mozetic, et al.
Published: (2021-07-01)

What do Cochrane systematic reviews say about ultrasound-guided vascular access?
by: Gabriela Araújo Attie, et al.

What do Cochrane systematic reviews say about interventions for autism spectrum disorders?
by: Larissa Lyra, et al.

Analysis of Cochrane Systematic Reviews about retinopathy of prematurity
by: Vânia Mozetic, et al.
Published: (2021-04-01)

What is Evidence-Based Ophthalmology? Introducing the Cochrane Eyes and Vision Group
by: Richard Wormald
Published: (2003-01-01)

Tribulus Terrestris for Female Sexual Dysfunction: A Systematic Review
by: Ana Luiza Cabrera Martimbianco, et al.
Published: (2020-08-01)

Cannabinoids in nature and medicine /
by: Lambert, Didier M.
Published: (2009)

Statins and/or fibrates for diabetic retinopathy: a systematic review and meta-analysis
by: Vânia Mozetic, et al.
Published: (2019-11-01)

Cannabinoids—Multifunctional Compounds, Applications and Challenges—Mini Review
by: Dominik Duczmal, et al.
Published: (2024-10-01)

Evidence in Context: High Risk of Bias in Medical Cannabis and Cannabinoid Clinical Trials Dictates the Need for Cautious Interpretation
by: Joshua D. Brown, et al.
Published: (2021-02-01)

Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21
by: Anne Katrin Schlag, et al.
Published: (2022-06-01)

Cannabinoid crystal polymorphism
by: Crist N. Filer
Published: (2022-04-01)

What do Cochrane systematic reviews say about diabetic retinopathy?
by: Vania Mozetic, et al.

Determination of the distribution of cannabinoids in cannais resin from the Lebanon using HPLC.Part III/
by: 496466 McDonald, Patrick A., et al.

Applications of Crowdsourcing in Evidence Synthesis: A Case Study of Cochrane Crowd
by: LI Xiao, QU Jiansheng, KOU Leilei
Published: (2023-02-01)

Evidence from Cochrane systematic reviews on pharmacological treatment compared to placebo for panic disorder
by: Manuelle Mastrorocco Brand Rosa, et al.
Published: (2022-09-01)

Overview of systematic reviews - a new type of study: part I: why and for whom?
by: Valter Silva, et al.

The use of cannabinoids in epilepsy as an example: medical, social, and legal aspects
by: R. G. Akzhigitov, et al.
Published: (2020-08-01)

Overview of systematic reviews - a new type of study. Part II
by: Valter Silva, et al.

MicroED and cannabinoid research
by: Crist N. Filer
Published: (2021-05-01)

The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products
by: Emilio Russo, et al.
Published: (2024-07-01)

Cannabinoids in Periodontology: Where Are We Now?
by: Yésica Carmona Rendón, et al.
Published: (2023-11-01)

Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
by: Jeffrey Y. Hergenrather, et al.
Published: (2020-01-01)

Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks
by: Samuel P. Ang, et al.
Published: (2023-01-01)

Evidence Based Management: What Managers Can Learn from (Good) Doctors?
by: Małgorzata Sidor-Rządkowska
Published: (2017-07-01)

An overview of analgesics - anticonvulsants, antidepressants, and other medications (Part 3)
by: R. van Rensburg, et al.
Published: (2019-07-01)

Cannabinoid hyper-emesis syndrome: An enigma
by: Neeraj Gupta, et al.
Published: (2013-01-01)

Cochrane and its prospects in Bosnia and Herzegovina: Relying on Cochrane Croatia
by: Mersiha Mahmić-Kaknjo, et al.
Published: (2015-05-01)

Brain Cannabinoid Systems as Targets for the Therapy of Neurological Disorders
by: Paul Consroe
Published: (1998-12-01)